Funding round

N-Power Medicine raises $32M Series B round

N-Power Medicine has raised $32M in a Series B round, announced on September 1, 2026. The company is Develops oncology research platforms and prospective external control arms. The round was led by Labcorp Venture Fund, with participation from Merck Global Health Innovation Fund, Innovatus Capital Partners, a leading U.S.-based biotechnology investor.

N-Power Medicine raised a $32M Series B to expand its community oncology research network and adoption of its ProECA technology.

Company

N-Power Medicine

Amount

$32M (~$32M)

Round

Series B

Sector

oncology research

Country

Announced

September 1, 2026

Track every raise, every day

This deal appeared in The Daily Raise, September 1, 2026. Get the next edition in your inbox.

Just raised too?

Turn your funding news into guaranteed media coverage while the momentum lasts.

Get featured